{"id":44787,"date":"2022-06-07T13:01:38","date_gmt":"2022-06-07T11:01:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/"},"modified":"2022-06-07T13:01:38","modified_gmt":"2022-06-07T11:01:38","slug":"cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/","title":{"rendered":"Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol\u00ae Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl"},"content":{"rendered":"
\n

\nInnovating Every Day.TM<\/sup><\/b>\n<\/p>\n

BRIDGEWATER, N.J.–(BUSINESS WIRE)–#chewable<\/a>–Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, announced today that the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,291,628 for Welchol\u00ae Chewable Bar, the Company\u2019s novel drug delivery system of Colesevelam that is easy to handle and ingest, which provides patent protection until 2037.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cCosette has now obtained valuable patent protection for a novel drug delivery system that can deliver high load therapeutics, increasing patient convenience and compliance. The patent is an important aspect of Cosette\u2019s mission of ‘Innovating Every Day’ and supports the continued development of our Welchol\u00ae franchise,\u201d said President and CEO of Cosette, Apurva Saraf.\n<\/p>\n

\nLearn more about Welchol\u00ae at welchol.com.\n<\/p>\n

\nAbout Cosette Pharmaceuticals, Inc.:<\/b>\n<\/p>\n

\nCosette Pharmaceuticals, Inc. is a US-based, fully integrated pharmaceutical company with capabilities in product development, manufacturing, and commercial operations. The current products focus on complex dosage forms including topical creams, ointments, oral liquids\/solutions, suppositories, and injectables. Cosette has a long history of quality manufacturing, consistent supply, and commercialization success, including two sites (in New Jersey and North Carolina) supported by 300+ dedicated employees across all functional areas. Cosette is backed by Avista Capital Partners, a healthcare focused private equity firm.\n<\/p>\n

\nFor more information, please visit: www.cosettepharma.com<\/a> and follow us on LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSerge Ilin-Schneider:<\/b> bd@cosettepharma.com<\/a>
Kian Kazemi:<\/b> sales@cosettepharma.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Innovating Every Day.TM BRIDGEWATER, N.J.–(BUSINESS WIRE)–#chewable–Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, announced today that the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,291,628 for Welchol\u00ae Chewable Bar, the Company\u2019s novel drug delivery system of Colesevelam that is easy to handle and ingest, which provides patent protection until 2037. \u201cCosette … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44787","6":"format-standard","7":"category-industry"},"yoast_head":"\nCosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol\u00ae Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol\u00ae Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Innovating Every Day.TM BRIDGEWATER, N.J.–(BUSINESS WIRE)–#chewable–Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, announced today that the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,291,628 for Welchol\u00ae Chewable Bar, the Company\u2019s novel drug delivery system of Colesevelam that is easy to handle and ingest, which provides patent protection until 2037. \u201cCosette ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-07T11:01:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220607005137\/en\/1464251\/21\/Apurva_headshot.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol\u00ae Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl\",\"datePublished\":\"2022-06-07T11:01:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\\\/\"},\"wordCount\":252,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607005137\\\/en\\\/1464251\\\/21\\\/Apurva_headshot.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\\\/\",\"name\":\"Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol\u00ae Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607005137\\\/en\\\/1464251\\\/21\\\/Apurva_headshot.jpg\",\"datePublished\":\"2022-06-07T11:01:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607005137\\\/en\\\/1464251\\\/21\\\/Apurva_headshot.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220607005137\\\/en\\\/1464251\\\/21\\\/Apurva_headshot.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol\u00ae Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol\u00ae Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/","og_locale":"en_US","og_type":"article","og_title":"Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol\u00ae Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl - Pharma Trend","og_description":"Innovating Every Day.TM BRIDGEWATER, N.J.–(BUSINESS WIRE)–#chewable–Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, announced today that the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,291,628 for Welchol\u00ae Chewable Bar, the Company\u2019s novel drug delivery system of Colesevelam that is easy to handle and ingest, which provides patent protection until 2037. \u201cCosette ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-07T11:01:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220607005137\/en\/1464251\/21\/Apurva_headshot.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol\u00ae Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl","datePublished":"2022-06-07T11:01:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/"},"wordCount":252,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220607005137\/en\/1464251\/21\/Apurva_headshot.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/","url":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/","name":"Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol\u00ae Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220607005137\/en\/1464251\/21\/Apurva_headshot.jpg","datePublished":"2022-06-07T11:01:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220607005137\/en\/1464251\/21\/Apurva_headshot.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220607005137\/en\/1464251\/21\/Apurva_headshot.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cosette-pharmaceuticals-receives-u-s-patent-us-11291628-for-welchol-chewable-bar-a-novel-oral-drug-delivery-system-to-deliver-colesevelam-hcl\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cosette Pharmaceuticals Receives U.S. Patent (US 11,291,628) For Welchol\u00ae Chewable Bar, A Novel Oral Drug Delivery System to Deliver Colesevelam Hcl"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44787"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44787\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}